Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?
ثبت نشده
چکیده
References 1 Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34–D41. 2 Gurtner HP. Aminorex and pulmonary hypertension. A review. Cor Vasa 1985; 27: 160–171. 3 Kay JM, Smith P, Heath D. Aminorex and the pulmonary circulation. Thorax 1971; 26: 262–270. 4 Simonneau G, Fartoukh M, Sitbon O, et al. Primary pulmonary hypertension associated with the use of fenfluramine derivatives. Chest 1998; 114: 195S–199S. 5 Savale L, Chaumais MC, Cottin V, et al. Pulmonary hypertension associated with benfluorex exposure. Eur Respir J 2012; 40: 1164–1172. 6 Chin KM, Channick RN, Rubin LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest 2006; 130: 1657–1663. 7 Montani D, Bergot E, Günther S, et al. Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 2012; 125: 2128–2137. 8 Groeneveldt JA, Gans SJM, Bogaard HJ, et al. Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition. Eur Respir J 2013; 42: 869–870. 9 Savale L, Sattler C, Günther S, et al. Pulmonary arterial hypertension in patients treated with interferon. Eur Respir J 2014; 44: 1627–1634. 10 Montani D, Seferian A, Savale L, et al. Drug-induced pulmonary arterial hypertension: a recent outbreak. Eur Respir Rev 2013; 22: 244–250. 11 Broadley KJ. The vascular effects of trace amines and amphetamines. Pharmacol Ther 2010; 125: 363–375. 12 Commission nationale de pharmacovigilance—Compte rendu de la réunion du mardi 25 mars 2008. http://ansm. sante.fr/var/ansm_site/storage/original/application/bd7be64de27e31df5c8182983443353f.pdf Date last accessed: May 12, 2015. 13 Seferian A, Chaumais MC, Savale L, et al. Drugs induced pulmonary arterial hypertension. Presse Méd 2013; 42: e303–310. 14 Walker AM, Langleben D, Korelitz JJ, et al. Temporal trends and drug exposures in pulmonary hypertension: an American experience. Am Heart J 2006; 152: 521–526. 15 Barst RJ, Abenhaim L. Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure. Heart 2004; 90: e42. 16 Souza R, Humbert M, Sztrymf B, et al. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 2008; 31: 343–348.
منابع مشابه
Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?
Pulmonary hypertension (PH) is defined as a mean pulmonary artery pressure ⩾25 mmHg, and can be associated with multiple conditions. The diagnostic strategy and treatment of PH is heavily reliant on accurately classifying patients [1]. We recently identified two patients presenting with rapidly fatal PH of unknown aetiology, who were subsequently diagnosed at post mortem with pulmonary tumour t...
متن کاملPulmonary tumour thrombotic microangiopathy due to adenocarcinoma of the lung. A cause of pulmonary hypertension.
متن کامل
A case of pulmonary tumour thrombotic microangiopathy.
Pulmonary tumour thrombotic microangiopathy (PTTM) is a rapidly progressive pulmonary disease that is a fatal complication of malignancy. It manifests clinically as subacute respiratory failure with pulmonary hypertension, progressive right sided heart failure, and sudden death. We describe here a case of PTTM associated with occult metastatic signet ring cell carcinoma of the stomach. Although...
متن کاملImatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer
Pulmonary tumour thrombotic microangiopathy (PTTM) is a rare complication of cancer, which can be lethal due to progressive pulmonary hypertension (PH). Several case reports have demonstrated that imatinib, a platelet-derived growth factor receptor-tyrosine kinase inhibitor, can improve severe PH in patients with PTTM.We describe the case of a 56-year-old woman. Her mean pulmonary arterial pres...
متن کاملSwitching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.
References 1 Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D34–D41. 2 von Herbay A, Illes A, Waldherr R, et al. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990; 66: 587–592. 3 Dorfmuller P, Gunther S, Ghigna MR, et al. Microvascular disease in chronic thromboemboli...
متن کامل